Remdesivir (Veklury) is an antiviral medication that treats several viral infections, including COVID-19. It may affect kidney health. Some experts believe that remdesivir is generally safe and ...

Add Yahoo as a preferred source to see more of our stories on Google. The coronavirus disease (COVID-19) outbreak in Cairo (Reuters) - Europe's drugs regulator said on Friday its safety panel found no ...

Feb 12 (Reuters) - A safety panel at the European Medicines Agency said on Friday there was no evidence that Gilead's GILD.O COVID-19 drug remdesivir caused kidney problems in some patients.

As Covid-19 infections continue to peak, researchers around the world are working at unprecedented speeds to manufacture disease prevention and treatment options to combat the ever-growing list of ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Gilead Sciences Inc. said it is recalling tens of thousands of vials of ...

Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known.

The World Health Organization has updated its ongoing guidance on Covid-19 medications to advise against using the antiviral drug remdesivir to treat hospitalized patients, no matter how severe their ...

While clinical trials suggest remdesivir isn't very effective in treating Covid-19, recent studies have shown that it does block Coronavirus activity. That apparent contradiction makes the antiviral ...

Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with ...

Feb 12 (Reuters) - Europe's drugs regulator said on Friday its safety panel found no evidence that Gilead's (GILD.O), opens new tab remdesivir caused kidney problems in some COVID-19 patients.